Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether markers of b-cell function can predict
changes in B-cell function over time in patients with type 2 diabetes mellitus (T2DM)
randomized to treatment with metformin or rosiglitazone.